Nikolaos Patsoukis

1 Patent

• US122584092025

  Method of Assessing the Efficacy of a Test Agent for Modulating Programmed Death 1 (PD-1) Signaling by Using Anti-phosphotyrosinylated PD-1 Monoclonal Antibodies

  President And Fellows Of Harvard College

  0 cites